Fengming Tang

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

Michael E. Nassif, Sheryl L. Windsor, Barry A. Borlaug et al. · Nature Medicine · 2021 · 604 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Recent Trends in Survival From Out-of-Hospital Cardiac Arrest in the United States

Paul S. Chan, Bryan McNally, Fengming Tang et al. · Circulation · 2014 · 568 citations

Health Professions, Emergency Medicine, Patient Safety +13

Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction

Michael E. Nassif, Sheryl L. Windsor, Fengming Tang et al. · Circulation · 2019 · 427 citations

Medicine, Cardiology, Pharmacology +17

Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure

Michael E. Nassif, Mohammed Qintar, Sheryl L. Windsor et al. · Circulation · 2021 · 274 citations · Full text

Medicine, Cardiology, Pharmacology +15

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program)

Mikhail Kosiborod, Marília Brito Gomes, Antonio Nicolucci et al. · Cardiovascular Diabetology · 2018 · 263 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +12